Showing results (41-50 of 212) with videos related to
Sort By:
Pageof 22
Molecular Imaging and Biology|September 22, 2021
ImmunoPET: harnessing antibodies for imaging immune cellsAnna M Wu, Neeta Pandit-TaskarJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 19, 2012
Advances in immuno-positron emission tomography: antibodies for molecular imaging in oncologyScott M Knowles, Anna M WuCancer Biotherapy & Radiopharmaceuticals|June 29, 2010
Positive progress in immunoPET--not just a coincidenceKatelyn E McCabe, Anna M WuMolecular Cancer Therapeutics|March 14, 2020
Therapeutic and Prophylactic Antitumor Activity of an Oral Inhibitor of Fucosylation in Spontaneous Mammary CancersMary L Disis, Lauren R Corulli, Ekram A Gad, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2005
In vivo drug-linker stability of an anti-CD30 dipeptide-linked auristatin immunoconjugateRussell J Sanderson, Michelle A Hering, Stephanie F James, et al.Current Radiopharmaceuticals|December 29, 2011
Protein targeting constructs in alpha therapyTove Olafsen, Jorgen Elgqvist, Anna M WuJournal of Labelled Compounds & Radiopharmaceuticals|March 15, 2018
Aligning physics and physiology: Engineering antibodies for radionuclide deliveryWen-Ting K Tsai, Anna M WuPlos One|February 24, 2015
The fucosylation inhibitor, 2-fluorofucose, inhibits vaso-occlusion, leukocyte-endothelium interactions and NF-ĸB activation in transgenic sickle miceJohn D Belcher, Chunsheng Chen, Julia Nguyen, et al.Bioorganic & Medicinal Chemistry Letters|June 13, 2020
Structure-activity relationships of tubulysin analoguesJoel R Courter, Joseph Z Hamilton, Nathaniel R Hendrick, et al.Cancer Research|March 22, 2003
Optical bioluminescence and positron emission tomography imaging of a novel fusion reporter gene in tumor xenografts of living micePritha Ray, Anna M Wu, Sanjiv S GambhirPageof 22